ENTRY       D09329                      Drug
NAME        Conatumumab (USAN/INN)
FORMULA     C6466H10006N1730O2024S40
EXACT_MASS  145554.2053
MOL_WEIGHT  145643.6104
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSQTLSL TCTVSGGSIS SGDYFWSWIR QLPGKGLEWI GHIHNSGTTY
            YNPSLKSRVT ISVDTSKKQF SLRLSSVTAA DTAVYYCARD RGGDYYYGMD VWGQGTTVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VDKYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSVLTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDLS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQGIS RSYLAWYQQK PGQAPSLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QFGSSPWTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H97, H49-H205, H266-H326, H372-H430, H231-H'231, H234-H'234, L23-L89, L135-L195, H225-L215, H'225-L'215; Glycosylation site: H302)
  TYPE      Peptide
EFFICACY    Antineoplastic, TRAIL receptor 2 agonist
  TYPE      Monoclonal antibody
TARGET      TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF10B (TRAILR2, CD262)
                 D09329  Conatumumab (USAN/INN)
DBLINKS     CAS: 896731-82-1
            PubChem: 96026009
///
